-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Elevation Oncology, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2020 to Q1 2025.
- Elevation Oncology, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was $6K, a 45.5% decline year-over-year.
- Elevation Oncology, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2025 was $38K, a 5.56% increase year-over-year.
- Elevation Oncology, Inc. annual Income Tax Expense (Benefit) for 2024 was $43K, a 43.3% increase from 2023.
- Elevation Oncology, Inc. annual Income Tax Expense (Benefit) for 2023 was $30K, a 20% increase from 2022.
- Elevation Oncology, Inc. annual Income Tax Expense (Benefit) for 2022 was $25K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)